Sunflower Pharmaceutical Group Co.,Ltd
SHZ: 002737.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi Guan
- Employees
- 5,727
- Headquarters
- Harbin, China
- IPO year
- 2014
- Market cap
- CN¥7.9B
- Website
- https://www.kuihuayaoye.com
Loading 002737…
Loading profile data…Frequently asked questions about 002737
What does Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) do?
Sunflower Pharmaceutical Group Co.,Ltd researches, develops, manufactures, and markets Chinese patent medicines in China. The company also produces chemical, biological, and health care medicines. Its products are used in therapeutic areas, such as pediatrics, gynecology, digestive system, respiratory and cold, rheumatism and bone disease, and c...
Where does 002737.SZ trade?
Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002737.SZ in?
Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sunflower Pharmaceutical Group Co.,Ltd?
Yi Guan is the chief executive officer of Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ).
Where is Sunflower Pharmaceutical Group Co.,Ltd headquartered?
Sunflower Pharmaceutical Group Co.,Ltd is headquartered in China.
Does 002737.SZ pay a dividend?
Yes — Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) paid a trailing twelve-month dividend of CNY 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002737.SZ go public?
Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) completed its initial public offering in 2014.